Back to search
FDAFDA · Food and drugs·Recall number D-0357-2022

GoodSense Aller.Ease, Fexofenadine hydrochloride 24 HR, 180 mg tablets, 30 count bottle, Made in the Czech Republic, Distributed by Perrigo Allergan MI., 49010, UPC 3 0113 0571 39 3; NDC 0113-0571-30,

Published January 12, 2022 · Recall initiated: July 27, 2021

Summary

FDA records drug Class II recall D-0357-2022, published January 12, 2022 and initiated July 27, 2021. Recalling firm: Perrigo Company PLC; Status: Terminated; Reported quantity: 3,168 bottles; Lot: Lot # 0MV2158, exp 6/1/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Perrigo Company PLC
Distributor
Nationwide in the USA
Lot
Lot # 0MV2158, exp 6/1/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was GoodSense Aller.Ease, Fexofenadine hydrochloride 24 HR, 180 mg tablets, 30 count bottle, Made in the Czech Republic, Distributed by Perrigo Allergan MI., 49010, UPC 3 0113 0571 39 3; NDC 0113-0571-30, recalled?

Yes. FDA published recall D-0357-2022 on January 12, 2022. Reported hazard: Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter